Low risk — use of or exposure to this product is not likely to cause adverse health consequences.
Dr. Sheffield's Triple Antibiotic Ointment Bacitracin 400 units Recalled by Faria Limited LLC dba Sheffield Pharmaceuticals Due to Failed Stability Specifications: Unable to meet shelf life...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Faria Limited LLC dba Sheffield Pharmaceuticals directly.
Affected Products
Dr. Sheffield's Triple Antibiotic Ointment Bacitracin 400 units, Neomycin Sulfate 3.5mg, Polymyxin-B Sulfate 5,000 units, First Aid Antibiotic Ointment, Net Wt. 0.33oz (9g)
Quantity: 105,744 tubes
Why Was This Recalled?
Failed Stability Specifications: Unable to meet shelf life expiry.
Where Was This Sold?
This product was distributed to 4 states: CA, GA, PA, WA
About Faria Limited LLC dba Sheffield Pharmaceuticals
Faria Limited LLC dba Sheffield Pharmaceuticals has 4 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report